Ocular Therapeutix Ownership | Who Owns Ocular Therapeutix?

Overview Forecast RevenueFinancials Chart Transcripts

Ocular Therapeutix Ownership Summary

Ocular Therapeutix is owned by 109.93% institutional investors, 0.87% insiders. Fmr is the largest institutional shareholder, holding 17.44% of OCUL shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.95% of its assets in Ocular Therapeutix shares.

OCUL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Ocular Therapeutix	109.93%	0.87%	-10.80%
Sector	Healthcare Stocks	35.49%	11.78%	52.72%
Industry	Biotech Stocks	34.84%	11.71%	53.45%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	32.65M	17.44%	$276.58M
Deep track capital, lp	19.69M	10.51%	$166.74M
Blackrock	11.52M	8.73%	$78.80M
Blackrock funding, inc. /de	16.13M	8.62%	$136.65M
Avoro capital advisors	12.31M	6.58%	$104.31M
Summer road	11.88M	6.34%	$100.62M
Vanguard group	11.58M	6.29%	$140.52M
Vr adviser	10.35M	5.53%	$87.64M
Price t rowe associates inc /md/	5.90M	3.15%	$49.95M
Point72 asset management	5.53M	2.96%	$46.88M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Summer road	11.88M	70.84%	$100.62M
Deltec asset management	2.34M	3.64%	$19.83M
Acuta capital partners	592.11K	3.54%	$5.02M
Vr adviser	10.35M	3.27%	$87.64M
Octagon capital advisors lp	3.17M	2.97%	$26.82M
Knoll capital management	600.40K	2.82%	$5.09M
Deep track capital, lp	19.69M	2.72%	$166.74M
Propel bio management	382.38K	2.03%	$3.23M
Logos global management lp	3.85M	1.63%	$32.61M
Birchview capital, lp	320.00K	1.54%	$2.71M

Top Buyers

Holder	Shares	% Assets	Change
Deep track capital, lp	19.69M	2.72%	11.62M
Price t rowe associates inc /md/	5.90M	0.01%	5.73M
Point72 asset management	5.53M	0.06%	4.52M
Blackrock	11.52M	0.00%	3.46M
Vr adviser	10.35M	3.27%	3.03M

Top Sellers

Holder	Shares	% Assets	Change
Adage capital partners gp	-	-	-4.63M
Janus henderson group	68.50K	0.00%	-4.16M
Tcg crossover management	1.65M	0.40%	-4.09M
Millennium management	34.01K	0.00%	-3.17M
Paradigm biocapital advisors lp	-	-	-2.94M

New Positions

Holder	Shares	% Assets	Change	Value
Commodore capital lp	2.58M	1.26%	2.58M	$21.81M
Vanguard fiduciary trust	1.25M	0.00%	1.25M	$10.55M
Sio capital management	968.60K	1.18%	968.60K	$8.20M
Readystate asset management lp	883.62K	0.34%	883.62K	$7.48M
Dimensional fund advisors lp	649.76K	0.00%	649.76K	$5.49M

Sold Out

Holder	Change
Parallel advisors	-1.00
Financial gravity asset management	-1.00
Federated hermes	-2.00
Nelson, van denburg & campbell wealth management group	-17.00
Clearstead advisors	-35.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	275	4.17%	205,831,607	7.46%	109	1.05%	174	4.82%	60	1.69%
Dec 31, 2025	60	-73.68%	18,632,527	-90.10%	10	0.09%	31	-74.59%	17	-71.67%
Sep 30, 2025	70	-63.92%	30,539,013	-80.55%	17	0.21%	28	-71.43%	23	-51.06%
Jun 30, 2025	192	-4.48%	156,898,610	16.16%	90	1.43%	96	3.23%	47	-20.34%
Mar 31, 2025	202	8.60%	137,366,906	2.63%	81	1.26%	93	-1.06%	60	57.89%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	13.03M	5.95%	339.91K
Fidelity Growth Company Fund	9.65M	4.43%	243.37K
Vanguard Total Stock Mkt Idx Inv	6.55M	3.01%	44.16K
Vanguard US Total Market Shares ETF	4.64M	2.92%	-
iShares Russell 2000 ETF	4.42M	2.02%	37.27K
Fidelity Growth Company K6	2.69M	1.23%	51.61K
Fidelity Series Growth Company	2.59M	1.19%	62.86K
Vanguard Institutional Extnd Mkt Idx Tr	1.95M	0.90%	85.89K
Fidelity Small Cap Index	1.82M	0.84%	20.75K
iShares Russell 2000 Growth ETF	1.55M	0.71%	20.81K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 23, 2026	Dugel Pravin	See Remarks	Sell	$166.06K
Feb 23, 2026	Kaiser Peter	Chief Development Officer	Sell	$23.27K
Feb 23, 2026	Heier Jeffrey S.	Chief Scientific Officer	Sell	$25.31K
Feb 23, 2026	Nayak Sanjay	Chief Strategy Officer	Sell	$14.56K
Feb 20, 2026	Waheed Nadia	Chief Medical Officer	Sell	$27.17K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	1	11
2025 Q4	-	8
2025 Q3	-	5
2025 Q2	1	5
2025 Q1	-	6

OCUL Ownership FAQ

Who Owns Ocular Therapeutix?

Ocular Therapeutix shareholders are primarily institutional investors at 109.93%, followed by 0.87% insiders and -10.80% retail investors. The average institutional ownership in Ocular Therapeutix's industry, Biotech Stocks , is 34.84%, which Ocular Therapeutix exceeds.

Who owns the most shares of Ocular Therapeutix?

Ocular Therapeutix’s largest shareholders are Fmr (32.65M shares, 17.44%), Deep track capital, lp (19.69M shares, 10.51%), and Blackrock (11.52M shares, 8.73%). Together, they hold 36.68% of Ocular Therapeutix’s total shares outstanding.

Does Blackrock own Ocular Therapeutix?

Yes, BlackRock owns 8.73% of Ocular Therapeutix, totaling 11.52M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 78.8M$. In the last quarter, BlackRock increased its holdings by 3.46M shares, a 42.87% change.

Who is Ocular Therapeutix’s biggest shareholder by percentage of total assets invested?

Summer road is Ocular Therapeutix’s biggest shareholder by percentage of total assets invested, with 70.84% of its assets in 11.88M Ocular Therapeutix shares, valued at 100.62M$.

Who is the top mutual fund holder of Ocular Therapeutix shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Ocular Therapeutix shares, with 5.95% of its total shares outstanding invested in 13.03M Ocular Therapeutix shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools